Patents Assigned to Hexacath
  • Patent number: 11813416
    Abstract: A catheter system and a method for performing body obstruction destruction are disclosed. The catheter comprises a catheter shaft comprising a proximal end and a distal end, including an outer tubular member and at least one inner tubular member disposed within the outer tubular member; a first fluid lumen defined between the inner tubular member and the outer tubular member and at least one second lumen defined by the inner tubular member; one or more fluid exit openings located at a distal end region of the catheter configured to permit fluid to exit the catheter from the first fluid lumen; fluid pressure means located external of the catheter ahead from the proximal end for delivering said fluid in the first fluid lumen at a pressure range predetermined to cause destruction of said obstruction.
    Type: Grant
    Filed: June 10, 2020
    Date of Patent: November 14, 2023
    Assignee: HEXACATH
    Inventors: Gilles Ascher, Bernard De Bruyne, Nico Pijls
  • Patent number: 11602618
    Abstract: The invention relates to an infusion catheter device. This catheter device 10 has an elongate, substantially tubular shape defining a longitudinal axis, a distal end (D) and a proximal end (P), configured to be introduced into a conduit (50) having an inner wall (54) and an outer wall (56) and comprising at least one partial or total obstruction (60) or occlusion to be treated, said device comprising, at its distal end (D), one or more infusion orifices (16, 18, 20, 22) for an infusion liquid (LI), and, upstream from the one or more infusion orifices, at the proximal side (P) of the infusion catheter (10), at least one obturating element (70) for temporary obturating, configured to treat said obstruction (60) or occlusion and to perform the infusion of the infusion liquid (LI) downstream from the obturating element (70) and in the obturating position. This device is suitable in particular for cardiac surgery and interventional cardiology.
    Type: Grant
    Filed: May 31, 2017
    Date of Patent: March 14, 2023
    Assignee: HEXACATH
    Inventors: Bernard De Bruyne, Nico Pijls, Gilles Charles Franklin Ascher
  • Patent number: 10716482
    Abstract: Catheter systems and methods for determining blood flow rates based on temperature measurements by thermodilution. The catheter may include a fluid lumen defined between inner and outer tubular members for delivering an indicator fluid, and a guidewire lumen defined by the inner tubular member. The catheter may include fluid infusion openings at the distal end region of the outer tubular member configured to permit the indicator fluid to exit the catheter from the fluid lumen, and a fluid hole located at the distal end region of the inner tubular member configured to permit the indicator fluid to pass from the fluid lumen into the guidewire lumen. A temperature sensor positioned on a guidewire may be positioned within the guidewire lumen to measure the temperature of the indicator fluid entering the guidewire lumen through the fluid hole. A blood flow rate may be calculated based on the measured temperature.
    Type: Grant
    Filed: April 24, 2014
    Date of Patent: July 21, 2020
    Assignee: HEXACATH
    Inventors: James M. Anderson, Jan Weber, Steven J Koch, Timothy S. Girton, Nico H J Pijls, Bernard De Bruyne
  • Patent number: 9186265
    Abstract: The invention relates to an implantable medical device. This implantable medical device (10) to be implanted at an implantation site comprises a proximal end (P), a central portion (C) and a distal end (D), characterized in that it comprises, at its proximal end (P), at least one means (20) for positioning the implantable device (10) at a precise point of a branching (E) of a blood vessel (V), such as a coronary artery. The invention provides precise, exact and almost perfect positioning of the implantable medical device 10 such as a stent 11 at the branching E of the blood vessel V to be treated, in order to treat the ostial lesions or stenoses that have been very difficult to treat until now.
    Type: Grant
    Filed: May 12, 2009
    Date of Patent: November 17, 2015
    Assignee: HEXACATH
    Inventors: Raul M. Valdesuso Aguilar, Gilles Ascher
  • Patent number: 9011519
    Abstract: An implantable medical device (10) comprises reservoirs (30) for receiving a water-soluble active agent or medicament (36) in the form of a solid deposit; and at least one biocompatible and biodegradable protecting/retaining layer (38) for protecting the active agent or medicament (36) until it reaches its site of implantation, said biocompatible and biodegradable protecting layer (38) comprising at least one biocompatible and biodegradable film-forming agent, and at least one hydrophobic, biocompatible, agent for controlling the disintegration rate of the protecting/retaining layer. The invention provides better protection of the active agent or medicament and better control of the disintegration rate of the protecting/retaining layer.
    Type: Grant
    Filed: February 20, 2009
    Date of Patent: April 21, 2015
    Assignees: Hexacath
    Inventors: Gilles Ascher, Edoardo Camenzind
  • Publication number: 20120172794
    Abstract: An implantable medical device (10) comprises reservoirs (30) for receiving a water-soluble active agent or medicament (36) in the form of a solid deposit; and at least one biocompatible and biodegradable protecting/retaining layer (38) for protecting the active agent or medicament (36) until it reaches its site of implantation, said biocompatible and biodegradable protecting layer (38) comprising at least one biocompatible and biodegradable film-forming agent, and at least one hydrophobic, biocompatible, agent for controlling the disintegration rate of the protecting/retaining layer. The invention provides better protection of the active agent or medicament and better control of the disintegration rate of the protecting/retaining layer.
    Type: Application
    Filed: February 20, 2009
    Publication date: July 5, 2012
    Applicant: HEXACATH
    Inventors: Gilles Ascher, Edoardo Camenzind
  • Patent number: 8197945
    Abstract: The invention relates to a mechanical piece having a structure comprising a substrate (1) and at least one surface coating layer (3) of nanometric thickness, for improving mechanical resistance, characterized in that it comprises between the substrate and the surface coating layer an essentially non ceramic, non porous adhesion layer of nanometric size; and said surface coating layer is an essentially non porous barrier layer (2) consisting essentially of an essentially stoechiometric titanium nitride layer.
    Type: Grant
    Filed: December 5, 2005
    Date of Patent: June 12, 2012
    Assignee: Hexacath
    Inventors: Gilles Ascher, Johannes Lammer
  • Publication number: 20110264189
    Abstract: The invention relates to an implantable medical device. This implantable medical device (10) to be implanted at an implantation site comprises a proximal end (P), a central portion (C) and a distal end (D), characterized in that it comprises, at its proximal end (P), at least one means (20) for positioning the implantable device (10) at a precise point of a branching (E) of a blood vessel (V), such as a coronary artery. The invention provides precise, exact and almost perfect positioning of the implantable medical device 10 such as a stent 11 at the branching E of the blood vessel V to be treated, in order to treat the ostial lesions or stenoses that have been very difficult to treat until now.
    Type: Application
    Filed: May 12, 2009
    Publication date: October 27, 2011
    Applicant: HEXACATH
    Inventors: Raul M. Valdesuso Aguilar, Gilles Ascher